MAPK variant effect atlas
Proteins / RET

RET

Proto-oncogene tyrosine-protein kinase receptor Ret

Receptor tyrosine kinase UniProt P07949 HSP90 client (literature): weak 3D structure ↓ 6 interaction partners · volcano ↗
Mutagenized 660–1114Kinase 724–1016Kinase11,114 aagrey box: mutagenized region

MAPK pathway activity (phosphorylated ERK2 reporter) under basal conditions. Scores are WT-relative: 1 = wild type.

10,106 variantsmissense decreased 25% · increased 12%1,634 dominant negative variants
Other cells fade; highlighted cells are outlined.
Annotation tracks
Structure
Function
Chaperone
Variant effect
Track legend & definitions
Secondary structure
alpha helix3-10 helixpi helixbeta strandbeta bridgeturnbendno_ss
DSSP assignment on the reference structure.
Relative SASA
0.000.250.500.751.00
Side-chain solvent accessibility (0 = buried, 1 = fully exposed). The pipeline calls a residue surface-exposed above 0.25.
pLDDT
50.062.575.087.5100.0
AlphaFold per-residue confidence. The analysis drops residues below 60.
Curated feature
Protein-protein interfaceCatalytic / active siteLigand / substrate pocketRegulatory elementOther annotation
UniProt / literature annotation, coloured by class. Red marks a curated protein-protein interface — the independent comparison for our predicted interfaces.
Annotated interface
yesno
Curated protein-interface residue, independent of any structure prediction in this study.
Active site
yesno
Curated catalytic / active-site residue.
Inter-domain contact
yesno
Residue contacting another domain of the same protein (all-atom), so a variant effect there may be intramolecular rather than at a PPI.
HSP90 contact
TrueFalseUnknown
Contacts HSP90 in the chaperone-client cryo-EM structures ('Unknown' where the protein was not mapped).
CDC37 contact
TrueFalseUnknown
Contacts CDC37. These positions report kinase foldability rather than a canonical binding surface.
Fraction decreased
0%25%50%75%100%
Fraction of variants at this position classified decreased in this assay (2.5th-percentile rule).
Fraction increased
0%25%50%75%100%
Fraction of variants at this position classified increased in this assay.
Fraction dominant-negative
0%25%50%75%100%
Fraction of variants at this position called dominant negative: basal pathway activity below the empty-vector threshold (basal activity only).
Domain Secondary structure Relative SASA pLDDT Curated feature Annotated interface Active site Inter-domain contact HSP90 contact CDC37 contact Fraction decreased Fraction increased Fraction dominant-negative Interface A V I L G F Y W C M P S T N Q D E H K R * -
Kinase 660 680 700 720 740 760 780 800 820 840 860 880 900 920 940 960 980 1000 1020 1040 1060 1080 1100 0.50 1.00 3.21
Click a position for its interactions and annotations — ■ the Interface strip marks positions in ≥1 supported interface (darker = more partners)

Structure · RET alone

Loading 3D viewer…

Interfaces of RET

One row per interface: complexes of the same pair and source whose interfaces overlap (IoU ≥ 0.3) are merged, as in the Fig. 6c,d volcano plots (median Cohen's d; q from the geometric-mean p). Supported: at least one complex with q < 0.05 and |d| ≥ 0.2 in either basal assay.

PartnerSourceActivity dq Abundance dqInterface positionsSupported
RETPDB-0.201.3e-28+0.461.7e-1920supportedStructure ↗
RAPH1RF2-PPI+0.213.1e-21-0.120.4686supportedStructure ↗
SORL1
PTKc_RET #2
RF2-PPI-0.253.2e-16+0.040.6097supportedStructure ↗
PLCG1AF-M+0.194.1e-12-0.558.7e-138supportedStructure ↗
PTPRARF2-PPI-0.201.3e-07+0.350.0055supportedStructure ↗
SORL1
PTKc_RET
RF2-PPI-0.229.8e-07-0.190.0958supportedStructure ↗
NTRK1AF-M-0.140.730-0.290.0193supportedStructure ↗
GNPTABRF2-PPI+0.132.1e-22-0.110.3198not supportedStructure ↗
CBLCRF2-PPI+0.175.6e-15-0.120.2074not supportedStructure ↗
GFRA1AF-M-0.140.173-0.170.2584not supportedStructure ↗